Flourishing in head and neck cancer survivors.
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
11
01
2022
received:
27
10
2021
accepted:
19
01
2022
pubmed:
13
3
2022
medline:
7
7
2022
entrez:
12
3
2022
Statut:
ppublish
Résumé
There is a growing cohort of head and neck cancer (HNC) patients affected by late- and long-term posttreatment side effects. Our study evaluates the relationship between the demographics, clinical characteristics, and posttreatment symptom burden with the subjective sense of flourishing among HNC survivors. A cross-sectional, single-center study of adult survivors of squamous cell cancer of the oral cavity, oropharynx, and larynx/hypopharynx who completed the Secure Flourishing Index (SFI) and patient-reported outcomes related to depression, anxiety, swallowing dysfunction, neck disability, and insomnia between November 2020 and April 2021. A total of 100, predominantly male (86%), survivors with an average age of 63.0 ± 9.6 were included in the study. Univariable analysis showed a significant association between higher flourishing scores and advanced age (95% CI: [0.011, 0.84], p = 0.0441), normal diet (95% CI: [5.79, 31.18], p = 0.0149), employment (95% CI: [1.24, 17.20], p = 0.0239), higher income (95% CI: [7.30, 27.72], p = 0.0248), and decreased reported difficulty paying for needs (95% CI: [-33.46, -18.88], p < 0.001). Flourishing was inversely associated with higher symptoms of depression (95% CI: [-2.23, -1.15], p < 0.001), anxiety (95% CI: [-1.92,-0.86], p < 0.001), swallowing dysfunction (95% CI: [-0.77, -0.26], p < 0.001), neck disability (95% CI: [-1.05, -0.35], p < 0.001), and insomnia (95% CI: [-1.12, -0.22], p = 0.004) in the multivariable analysis. Common late- and long-term side effects of HNC treatment and financial hardship are associated with lower levels of flourishing or a more negative perception of life after treatment. Results highlight the importance of symptom burden for survivors' overall evaluation of their quality of life.
Sections du résumé
BACKGROUND
There is a growing cohort of head and neck cancer (HNC) patients affected by late- and long-term posttreatment side effects. Our study evaluates the relationship between the demographics, clinical characteristics, and posttreatment symptom burden with the subjective sense of flourishing among HNC survivors.
METHODS
A cross-sectional, single-center study of adult survivors of squamous cell cancer of the oral cavity, oropharynx, and larynx/hypopharynx who completed the Secure Flourishing Index (SFI) and patient-reported outcomes related to depression, anxiety, swallowing dysfunction, neck disability, and insomnia between November 2020 and April 2021.
RESULTS
A total of 100, predominantly male (86%), survivors with an average age of 63.0 ± 9.6 were included in the study. Univariable analysis showed a significant association between higher flourishing scores and advanced age (95% CI: [0.011, 0.84], p = 0.0441), normal diet (95% CI: [5.79, 31.18], p = 0.0149), employment (95% CI: [1.24, 17.20], p = 0.0239), higher income (95% CI: [7.30, 27.72], p = 0.0248), and decreased reported difficulty paying for needs (95% CI: [-33.46, -18.88], p < 0.001). Flourishing was inversely associated with higher symptoms of depression (95% CI: [-2.23, -1.15], p < 0.001), anxiety (95% CI: [-1.92,-0.86], p < 0.001), swallowing dysfunction (95% CI: [-0.77, -0.26], p < 0.001), neck disability (95% CI: [-1.05, -0.35], p < 0.001), and insomnia (95% CI: [-1.12, -0.22], p = 0.004) in the multivariable analysis.
CONCLUSIONS
Common late- and long-term side effects of HNC treatment and financial hardship are associated with lower levels of flourishing or a more negative perception of life after treatment. Results highlight the importance of symptom burden for survivors' overall evaluation of their quality of life.
Identifiants
pubmed: 35277936
doi: 10.1002/cam4.4636
pmc: PMC9249981
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2561-2575Informations de copyright
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Head Neck. 2018 Jul;40(7):1443-1452
pubmed: 29573016
Dysphagia. 2017 Feb;32(1):83-89
pubmed: 27538876
Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395
pubmed: 30078696
Spine (Phila Pa 1976). 2006 Mar 1;31(5):598-602
pubmed: 16508559
Head Neck. 2013 Dec;35(12):1707-12
pubmed: 24142523
Cancer Treat Rev. 2012 Dec;38(8):1033-49
pubmed: 22542950
JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1213-1219
pubmed: 29075744
Psychooncology. 2005 Jun;14(6):429-41
pubmed: 15376284
Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20
pubmed: 16084801
Support Care Cancer. 2021 Aug;29(8):4473-4483
pubmed: 33454834
Br J Oral Maxillofac Surg. 2016 Jul;54(6):e45-51
pubmed: 26923873
Oral Oncol. 2019 Aug;95:187-193
pubmed: 31345389
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1002-1011
pubmed: 28721881
Indian J Palliat Care. 2017 Oct-Dec;23(4):445-450
pubmed: 29123353
Head Neck. 2004 Sep;26(9):785-91
pubmed: 15350024
J Affect Disord. 2020 Mar 15;265:395-401
pubmed: 32090765
Cancer Med. 2022 Jul;11(13):2561-2575
pubmed: 35277936
Psychosom Med. 2016 Jul-Aug;78(6):716-27
pubmed: 27187854
Psychol Health Med. 2016 Jul;21(5):562-70
pubmed: 26683266
ANS Adv Nurs Sci. 2020 Apr/Jun;43(2):172-189
pubmed: 31922987
J Affect Disord. 2012 Dec 10;141(2-3):343-51
pubmed: 22727334
Oral Oncol. 2015 Aug;51(8):787-94
pubmed: 26027851
J Hand Ther. 2017 Oct - Dec;30(4):407-419
pubmed: 28237074
Radiat Oncol. 2016 Feb 27;11:32
pubmed: 26922239
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
Clin Oncol (R Coll Radiol). 2016 Jul;28(7):451-8
pubmed: 27094976
J Gen Intern Med. 2021 Jan;36(1):248-250
pubmed: 33078296
Arch Phys Med Rehabil. 2008 Jan;89(1):69-74
pubmed: 18164333
J Orthop Sports Phys Ther. 2009 May;39(5):400-17
pubmed: 19521015
Radiother Oncol. 2007 Oct;85(1):74-82
pubmed: 17673322
Ann Otol Rhinol Laryngol. 2015 May;124(5):351-4
pubmed: 25358607
Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):380-4
pubmed: 19380361
Spine (Phila Pa 1976). 2007 Dec 15;32(26):3047-51
pubmed: 18091500
J Manipulative Physiol Ther. 1998 Feb;21(2):75-80
pubmed: 9502061
Oral Oncol. 2012 Oct;48(10):923-937
pubmed: 22525604
Head Neck. 1997 Sep;19(6):466-73
pubmed: 9278753
J Cancer Surviv. 2018 Oct;12(5):619-631
pubmed: 29770954
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Head Neck. 2015 Nov;37(11):1557-62
pubmed: 24912475
J Gen Intern Med. 2006 Jun;21(6):547-52
pubmed: 16808734
J Manipulative Physiol Ther. 1991 Sep;14(7):409-15
pubmed: 1834753
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8148-8156
pubmed: 28705870
Ann Otol Rhinol Laryngol. 2008 Dec;117(12):919-24
pubmed: 19140539
J Pain. 2014 Oct;15(10):1015-22
pubmed: 25043982
Expert Opin Pharmacother. 2015;16(16):2409-22
pubmed: 26513647
Spine J. 2009 Oct;9(10):802-8
pubmed: 19632904
J Clin Oncol. 2008 Jul 20;26(21):3582-9
pubmed: 18559875
J Cancer Res Ther. 2010 Jan-Mar;6(1):15-21
pubmed: 20479541
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
Clin Nutr. 2007 Dec;26(6):710-7
pubmed: 17954003
Soc Indic Res. 2021;155(3):1137-1157
pubmed: 33612917
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Stress Health. 2012 Dec;28(5):362-7
pubmed: 22972767
J Affect Disord. 2007 Apr;99(1-3):139-45
pubmed: 17049999
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Otolaryngol Head Neck Surg. 2020 Oct;163(4):763-770
pubmed: 32427536
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Clin Exp Otorhinolaryngol. 2013 Sep;6(3):117-26
pubmed: 24069513
Dysphagia. 1994 Winter;9(1):1-6
pubmed: 8131418
Otolaryngol Head Neck Surg. 2020 Jan;162(1):64-72
pubmed: 31613686
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941